Mirum Pharmaceuticals reported cash from operations of -$44.25M and free cash flow of -$44.27M for the quarter ended Jun 2026, down 467.5% year over year. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||
| Net Income | -47.11M | 57.28M | -36.61M | -26.92M | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -25.28M | -24.64M | -14.23M | -23.79M | -14.68M | -5.86M | 2.90M | -5.73M | -790.15M | -67.23M | ||||||||||
| Share-based CompensationStock Comp. | 7.42M | 5.56M | 8.15M | 8.38M | 8.33M | 6.90M | 9.45M | 9.52M | 9.59M | 9.72M | 11.45M | 11.84M | 11.91M | 13.25M | 15.80M | 18.47M | 18.13M | 19.03M | 36.20M | 292.89M | ||||||||||
| Cash from OperationsCash from Ops. | -34.20M | -33.15M | -39.67M | -20.17M | -26.02M | -34.27M | -18.77M | -17.33M | -18.22M | -16.62M | 15.21M | -3.80M | 3.98M | -5.07M | -1.96M | 12.04M | 39.68M | 6.07M | -228.76M | -44.25M | ||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.09M | -0.15M | 0.10M | 0.00M | 0.58M | 1.02M | 0.83M | 0.63M | 0.23M | 0.03M | ||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.09M | -0.28M | 0.31M | 0.41M | 0.40M | 0.41M | 0.41M | 0.42M | 0.42M | 0.43M | 0.43M | 0.44M | 0.44M | 0.45M | 0.66M | |||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.08M | 0.34M | 0.34M | 0.60M | 1.10M | 1.20M | 1.34M | 1.34M | 2.66M | 5.49M | 5.66M | 5.85M | 6.05M | 6.06M | 6.05M | 6.06M | 6.06M | 6.07M | 6.87M | 6.94M | ||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 4.61M | 6.12M | 2.35M | 7.66M | 0.67M | 10.66M | 12.51M | 20.13M | -12.97M | 5.43M | 8.10M | 10.86M | 16.83M | 9.07M | 3.15M | 19.01M | 12.89M | 13.74M | ||||||||||||
| Change in InventoryChange Inventory | 0.49M | 0.07M | 1.18M | 2.80M | -0.60M | 0.78M | 0.99M | 0.44M | -1.23M | 0.96M | 1.08M | 0.90M | 0.21M | 2.67M | 2.33M | 1.16M | 2.28M | 1.92M | -0.40M | |||||||||||
| Change in Accured ExpensesChange Accured Exp. | 3.78M | 9.02M | -8.07M | 8.89M | 6.83M | -0.01M | -1.21M | 9.18M | 10.29M | 12.53M | 11.28M | 6.94M | 12.75M | 9.34M | 11.74M | 10.58M | 24.35M | 3.44M | 57.24M | -19.06M | ||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.02M | 0.00M | 0.02M | 0.02M | 0.24M | 0.04M | 0.07M | 0.01M | 0.78M | 0.18M | 0.02M | 0.04M | 0.13M | 0.19M | 0.60M | 0.66M | 0.02M | |||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 47.50M | 38.00M | 36.50M | 38.80M | 38.00M | 27.00M | 64.50M | 55.50M | 30.00M | 3.00M | 7.75M | 12.14M | 17.43M | 25.06M | 18.82M | 13.11M | 33.89M | 25.85M | ||||||||||||
| Cash from Investing ActivitiesCash from Investing | -2.24M | 108.02M | 36.50M | 23.97M | -79.53M | 26.76M | 27.02M | 50.55M | -182.76M | -2.00M | -0.01M | -72.72M | -18.04M | 0.64M | -16.13M | -6.60M | -2.23M | 1.01M | -11.57M | -159.99M | ||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 17.38M | -13.47M | 82.44M | -0.28M | -2.88M | -192.69M | 397.94M | -0.16M | 1.21M | 7.29M | 3.86M | 5.34M | 6.36M | 8.69M | 16.10M | 9.00M | 259.95M | |||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.34M | 0.61M | 18.10M | 5.25M | 86.07M | -0.33M | 12.99M | 114.71M | 207.13M | 1.78M | 1.21M | 7.29M | 3.86M | 5.34M | 6.36M | 8.69M | 16.10M | 9.00M | 270.08M | 211.44M | ||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 2.36M | 1.48M | 2.17M | 1.30M | 2.07M | |||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 27.60M | 27.60M | 14.48M | |||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.01M | -0.00M | -0.05M | -0.02M | 0.09M | 0.19M | -0.11M | -0.32M | 0.11M | 0.11M | -0.12M | 0.09M | -1.38M | 1.05M | 2.23M | 0.35M | -0.41M | -1.27M | -1.37M | |||||||||||
| Change in Cash | -36.09M | 75.50M | 14.93M | 9.00M | -19.51M | -7.76M | 21.42M | 147.81M | 5.83M | -16.73M | 16.52M | -69.35M | -10.10M | -0.47M | -10.68M | 16.36M | 53.90M | 15.66M | 28.48M | 5.82M | ||||||||||
| Free Cash FlowFCF | -34.22M | -33.15M | -39.67M | -20.19M | -26.04M | -34.51M | -18.82M | -17.40M | -18.22M | -16.62M | 15.20M | -4.58M | 3.80M | -5.09M | -2.00M | 11.91M | 39.49M | 5.47M | -229.43M | -44.27M | ||||||||||
| Net Cash FlowNCF | -36.09M | 75.49M | 14.94M | 9.04M | -19.49M | -7.84M | 21.23M | 147.92M | 6.15M | -16.84M | 16.40M | -69.23M | -10.19M | 0.91M | -11.74M | 14.13M | 53.55M | 16.07M | 29.75M | 7.20M |